Microbot Medical Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $7 Price Target
HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $7
HC Wainwright & Co. : The Microbot Medical (MBOT.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $8.00 to $7.00.
Microbot Medical Analyst Ratings
HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $7
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target
Microbot Medical Analyst Ratings
Promising Preclinical Outcomes Propel Buy Rating for Microbot Medical: A Look Into LIBERTY Robotic Surgical System
Analysts Are Bullish on These Healthcare Stocks: AIM ImmunoTech (AIM), Microbot Medical (MBOT)
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target
H.C. Wainwright Sticks to Its Buy Rating for Microbot Medical (MBOT)
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target
H.C. Wainwright Keeps Their Buy Rating on Microbot Medical (MBOT)
HC Wainwright Adjusts Price Target on Microbot Medical to $8 From $20, Keeps Buy Rating
HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $8
Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and Microbot Medical (MBOT)